Storia in 7 fonti

AstraZeneca’s Wainua fails main goal in late-stage heart disease trial

Drug developed with Ionis could not reduce cardiovascular deaths or recurring heart problems

Raccontata da

cnbc.com

thehindubusinessline.com

endpoints.news

economictimes.indiatimes.com

statnews.com

ilsole24ore.com

irishtimes.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 g fa

AstraZeneca’s Wainua fails main goal in late-stage heart disease trial

Drug developed with Ionis could not reduce cardiovascular deaths or recurring heart problems

originale

Timeline cronologica

giovedì 9 luglio 2026·cnbc.com
AstraZeneca stock dives 9% after heart drug trial misses target
A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.
giovedì 9 luglio 2026·thehindubusinessline.com
AstraZeneca’s Wainua fails main goal in late-stage heart disease trial
Drug developed with Ionis could not reduce cardiovascular deaths or recurring heart problems

economictimes.indiatimes.com

1 g fa

AstraZeneca shares slide after Ionis-partnered drug fails late-stage heart disease trial

AstraZeneca shares fell after Wainua failed a key trial. The drug did not reduce cardiovascular deaths or heart problems. Wainua showed no effect in patients already on stabilizer therapy. A subgroup taking the drug…

Leggi questa versione → originale

irishtimes.com1 g fa

AstraZeneca shares slide 9% after heart treatment disappoints in trial

UK pharmaceutical company said Wainua drug did not meet goal of reducing cardiovascular deaths

Leggi questa versione → originale

endpoints.news1 g fa

AstraZeneca sinks on unexpected heart drug trial failure

AstraZeneca shares sink up to 9% after Wainua misses cardiovascular endpoint in Phase 3 ATTR-CM trial with partner Ionis.

Leggi questa versione → originale

cnbc.com1 g fa

AstraZeneca stock dives 9% after heart drug trial misses target

A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.

Leggi questa versione → originale

statnews.com1 g fa

AstraZeneca, Ionis report major trial failure with heart disease drug

AstraZeneca and Ionis reported a notable trial failure Thursday in a heart disease that's become an increasingly competitive market for drugmakers.

Leggi questa versione → originale

giovedì 9 luglio 2026·

endpoints.news

AstraZeneca sinks on unexpected heart drug trial failure

AstraZeneca shares sink up to 9% after Wainua misses cardiovascular endpoint in Phase 3 ATTR-CM trial with partner Ionis.

giovedì 9 luglio 2026·

economictimes.indiatimes.com

AstraZeneca shares slide after Ionis-partnered drug fails late-stage heart disease trial

AstraZeneca shares fell after Wainua failed a key trial. The drug did not reduce cardiovascular deaths or heart problems. Wainua showed no effect in patients already on stabilizer…

giovedì 9 luglio 2026·

statnews.com

AstraZeneca, Ionis report major trial failure with heart disease drug

AstraZeneca and Ionis reported a notable trial failure Thursday in a heart disease that's become an increasingly competitive market for drugmakers.

giovedì 9 luglio 2026·

ilsole24ore.com

A Londra scivolone di Astrazeneca dopo fallimento trial Wainua per malattia cardiaca

Il farmaco ha fallito l'obiettivo di ridurre i decessi cardiovascolari e le recidive di problemi cardiaci in una sperimentazione di fase avanzata

giovedì 9 luglio 2026·

irishtimes.com

AstraZeneca shares slide 9% after heart treatment disappoints in trial

UK pharmaceutical company said Wainua drug did not meet goal of reducing cardiovascular deaths